Min Su

Title: Innovator Spotlight: Min Su and His Breakthrough Patent in Mood Disorder Treatment

Introduction: Min Su is an accomplished inventor based in Kunming, China. With a keen focus on pharmaceutical innovations, he has contributed significantly to the field through his inventive work. His passion for improving medical treatments has led him to develop a notable patent that holds promise for the treatment of mood disorders.

Latest Patents: Min Su holds one patent titled "Polymorph of triaryldimethylpiperazine dihydrochloride and preparation method and application thereof." This patent discloses five polymorphic forms (B, P, F, J, O) of a compound aimed at creating medications for preventing or treating mood disorders and diseases related to the δ opioid receptor. The innovative preparation methods outlined in the patent stand to enhance the efficacy of potential treatments in the pharmaceutical industry.

Career Highlights: Min Su is currently associated with the Yunnan Institute of Materia Medica, where he continues to engage in research and development focused on medicinal innovations. His work demonstrates a commitment to advancing medical science and improving patient outcomes.

Collaborations: Throughout his career, Min Su has collaborated with notable coworkers, including Jingkun Wang and Zhaoyun Zhu. These partnerships have fostered a creative environment conducive to groundbreaking research and the development of new therapeutic solutions.

Conclusion: Min Su's contributions to the field of medicinal chemistry, particularly his work on polymorphic forms of triaryldimethylpiperazine dihydrochloride, illustrate his dedication to innovation in healthcare. As he continues his research at the Yunnan Institute of Materia Medica, the potential impact of his work on mood disorder treatments remains significant.